Volition Announces Finger-Prick Detection of Nucleosomes for Sepsis Testing

VolitionRx Limited has achieved a significant milestone by successfully detecting nucleosomes in capillary blood from sepsis patients using a lateral flow prototype. This finger-prick test allows for rapid and decentralized testing in various settings, including hospitals and home use, potentially expanding the market for sepsis diagnostics significantly. The technology aims to facilitate early detection of immune disruptions and improve clinical decision-making.